[

covid-19 vaccine candidate

]
A health worker collects swab samples for Covid-19 testing from a man at Sanjay Enclave in New Delhi on November 21.(Sanchit Khanna/HT PHOTO)

Human trials of Russia’s Covid-19 vaccine candidate to begin in India this week

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON NOV 22, 2020 10:06 AM IST
In India, five Covid-19 vaccine candidates are in advanced stages of development. Four of the vaccine candidates are undergoing the phase II and III and another one phase I and II of trials.
Close
Parliamentarians in the Lok Sabha after it adjourned sine die at Parliament House on Wednesday.(PTI)
Parliamentarians in the Lok Sabha after it adjourned sine die at Parliament House on Wednesday.(PTI)

Monsoon session: Govt supporting 8 Covid-19 vaccine candidates, minister tells LS

By Anonna Dutt | Hindustan Times, New Delhi
UPDATED ON SEP 24, 2020 10:16 AM IST
The Department for Biotechnology is supporting the eight vaccine candidates at a cost of Rs 75 crore, 17 proposals for diagnostic devices at a cost of Rs 10 crore and 13 possible therapeutic interventions at a cost of Rs 9.6 crore
Close
Serum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates that are in different stages of trials. (Image used for representation).(REUTERS PHOTO.)
Serum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates that are in different stages of trials. (Image used for representation).(REUTERS PHOTO.)

Both indigenous Covid-19 vaccine candidates showed excellent safety profile: MoS (health) in Lok Sabha

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON SEP 18, 2020 11:56 PM IST
Characterization of the vaccine candidate has been undertaken at ICMR-NIV followed by safety and tolerability studies in small animals like rats, mice and rabbits.
Close
Moderna had enrolled 25,296 participants out of a planned 30,000 in its late-stage study as of Wednesday.(REUTERS)
Moderna had enrolled 25,296 participants out of a planned 30,000 in its late-stage study as of Wednesday.(REUTERS)

Moderna sees 20 million doses of Covid-19 vaccine candidate by year end

By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 18, 2020 09:41 PM IST
Vaccines and treatments are seen as essential in controlling the Covid-19 pandemic that has shown no signs of slowing and killed over 944,000 people worldwide.
Close
Phase 1 clinical trials of both Bharat Biotech and Cadilla Healthcare vaccines have shown positive results, the health ministry says.(PTI)
Phase 1 clinical trials of both Bharat Biotech and Cadilla Healthcare vaccines have shown positive results, the health ministry says.(PTI)

30 Covid-19 vaccine candidates under development, Govt informs Lok Sabha

By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON SEP 18, 2020 08:18 PM IST
Phase 1 clinical trials of both Bharat Biotech and Cadilla Healthcare vaccines have shown positive results, the health ministry says.
Close
In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford.(AP)
In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford.(AP)

Oxford’s Covid-19 vaccine candidate is safe, early results show

By Prasun Sonwalkar | Hindustan Times, London
UPDATED ON JUL 20, 2020 07:57 PM IST
The Lancet said the current trial is too preliminary to confirm whether the new vaccine meets these requirements, but phase 2 (in the UK only) and phase 3 trials to confirm whether it effectively protects against SARS-CoV-2 infection are happening in the UK, Brazil and South Africa.
Close
SHARE
Story Saved